AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,982 | -5.8% | 5,351 | -3.2% | 0.00% | – |
| Q2 2023 | $397,170 | +19.4% | 5,527 | +2.5% | 0.00% | – |
| Q1 2023 | $332,578 | -21.5% | 5,392 | -1.9% | 0.00% | – |
| Q4 2022 | $423,829 | +69.5% | 5,495 | -1.9% | 0.00% | – |
| Q3 2022 | $250,000 | -69.3% | 5,600 | -73.7% | 0.00% | -100.0% |
| Q2 2022 | $815,000 | -7.3% | 21,287 | +0.2% | 0.00% | 0.0% |
| Q1 2022 | $879,000 | +9.6% | 21,252 | -0.0% | 0.00% | 0.0% |
| Q4 2021 | $802,000 | +14.1% | 21,253 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $703,000 | -51.0% | 21,295 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $1,435,000 | +19.5% | 21,260 | +0.2% | 0.00% | 0.0% |
| Q1 2021 | $1,201,000 | -28.9% | 21,228 | +2.4% | 0.00% | -50.0% |
| Q4 2020 | $1,689,000 | +14.3% | 20,733 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,478,000 | -13.3% | 20,733 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,705,000 | +2839.7% | 20,733 | +1973.3% | 0.00% | – |
| Q1 2020 | $58,000 | -44.2% | 1,000 | 0.0% | 0.00% | – |
| Q4 2019 | $104,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |